Catamaran Bio
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $42M
Investors
- 5
About Catamaran Bio
Catamaran Bio, Inc.Founded in 2020 and headquartered in Cambridge, US, Catamaran Bio, Inc. is dedicated to the development of advanced cell therapies.Catamaran Bio specializes in innovative cell therapies, primarily focusing on engineering Natural Killer (NK) cell therapies aimed at treating solid tumors and various types of cancer. Their flagship offering is the TAILWIND® platform, a proprietary suite of technologies designed to safely and effectively engineer, expand, and process NK cells into allogeneic CAR-NK cell therapy products.Catamaran Bio generates revenue primarily through strategic partnerships and collaborations focused on the development and manufacturing of its CAR-NK cell therapies. The company engages in B2B transactions with pharmaceutical companies, academic institutions, and healthcare providers, utilizing licensing agreements and collaborative research contracts that may involve milestones and royalties. The company aims to enhance its TAILWIND® platform and introduce new cell therapies targeting specific cancers within the next two years. Additionally, Catamaran Bio intends to enter European markets by 2023, capitalizing on the growing demand for innovative cancer treatments.
Who invested in Catamaran Bio
5 investors across 1 round
See all investors in Catamaran Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 23, 2020
Amount
$42M
Investors
Questions about Catamaran Bio
Who invested in Catamaran Bio?
Catamaran Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Catamaran Bio raised?
Catamaran Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Catamaran Bio last raise money?
Catamaran Bio's most recent round on record is a Series A, in Nov 2020.
What does Catamaran Bio do?
Catamaran Bio is a biotechnology company.
Where is Catamaran Bio headquartered?
Catamaran Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Catamaran Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Catamaran Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Catamaran Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.